Drugmakers’ spending on stock, dividends and executive pay exceeds research, democrats say

By | July 9, 2021
The largest drug companies are far more interested in enriching themselves and investors than in developing new drugs, according to a House committee report released Thursday that argues the industry can afford to charge Medicare less for prescriptions.